Picture of Adocia SA logo

ADOC Adocia SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Adocia reports topline results of Biochaperone Glucagon Phase 1 study

Nov 20 (Reuters) - ADOCIA SA  ADOC.PA : 
    * ADOCIA REPORTS TOPLINE RESULTS OF BIOCHAPERONE GLUCAGON 
PHASE 1 
STUDY 
    * BIOCHAPERONE GLUCAGON WAS FOUND TO BE SAFE AND WELL 
TOLERATED 
IN PEOPLE WITH TYPE 1 DIABETES 
    * BIOCHAPERONE GLUCAGON DEMONSTRATED EFFICACY IN RESCUING 
PARTICIPANTS FROM MEDICALLY INDUCED HYPOGLYCEMIA IN MEDIAN TIME 
OF 11 MINS 
 
Source text for Eikon:  ID:nBw2gYx2Ra  
Further company coverage:  ADOC.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Adocia SA

See all news